Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. College of Oral Medicine /口腔醫學院
  3. Institute of Oral Sciences/口腔科學研究所
  4. ERβ targets ZAK and attenuates cellular hypertrophy via SUMO‐1 modification in H9c2 cells
 
  • Details
Options

ERβ targets ZAK and attenuates cellular hypertrophy via SUMO‐1 modification in H9c2 cells

Journal
Journal of Cellular Biochemistry
Journal Volume
119
Journal Issue
9
Start Page
7855-7864
ISSN
0730-2312
1097-4644
Date Issued
2018-06-22
Author(s)
Peiying Pai
Marthandam Asokan Shibu
Ruey‐Lin Chang
Jaw‐Ji Yang  
Chia‐chi Su
Chao‐Hung Lai
Hung‐En Liao
Vijaya Padma Viswanadha
Wei‐Wen Kuo
Chih‐Yang Huang
DOI
10.1002/jcb.27199
URI
https://scholars.csmu.edu.tw/handle/123456789/3075
Abstract
<jats:title>Abstract</jats:title><jats:p>Aberrant expression of leucine zipper‐ and sterile ɑ motif‐containing kinase (ZAK) observed in pathological human myocardial tissue is associated with the progression and elevation of hypertrophy. Our previous reports have correlated high levels of estrogen (E2) and abundant estrogen receptor (ER) α with a low incidence of pathological cardiac‐hypertrophy and heart failure in the premenopause female population. However, the effect of elevated ERβ expression is not well known yet. Therefore, in this study, we have analyzed the cardioprotective effects and mechanisms of E2 and/or ERβ against ZAK overexpression–induced cellular hypertrophy. We have used transient transfection to overexpress ERβ into the ZAK tet‐on H9c2 cells that harbor the doxycycline‐inducible ZAK plasmid. The results show that ZAK overexpression in H9c2 cells resulted in hypertrophic effects, which was correlated with the upregulation of p‐JNK and p‐p38 MAPKs and their downstream transcription factors c‐Jun and GATA‐4. However, ERβ and E2 with ERβ overexpressions totally suppressed the effects of ZAK overexpression and inhibited the levels of p‐JNK, p‐p38, c‐Jun, and GATA‐4 effectively. Our results further reveal that ERβ directly binds with ZAK under normal conditions; however, ZAK overexpression reduced the association of ZAK‐ERβ. Interestingly, increase in ERβ and E2 along with ERβ overexpression both enhanced the binding strengths of ERβ and ZAK and reduced the ZAK protein level. ERβ overexpression also suppressed the E3 ligase‐casitas B‐lineage lymphoma (CBL) and attenuated CBL‐phosphoinositide 3‐kinase (PI3K) protein association to prevent PI3K protein degradation. Moreover, ERβ and/or E2 blocked ZAK nuclear translocation via the inhibition of small ubiquitin‐like modifier (SUMO)‐1 modification. Taken together, our results further suggest that ERβ overexpression strongly suppresses ZAK‐induced cellular hypertrophy and myocardial damage.</jats:p>
SDGs

[SDGs]SDG3

[SDGs]SDG5

Publisher
Wiley
Type
journal-article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback